Arthur He
Stock Analyst at HC Wainwright & Co.
(0)
# 5021
Out of 5,329 analysts
81
Total ratings
21.57%
Success rate
-34.84%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ADAG Adagene | Reiterates: Buy | 8 8 | 1.58 | 406.33% | 10 | Apr 3, 2025 | |
ADAP Adaptimmune Therapeu... | Maintains: Buy | 4 3 | 0.28 | 971.43% | 6 | Apr 1, 2025 | |
BCAB BioAtla | Reiterates: Neutral | n/a | n/a | n/a | 8 | Mar 31, 2025 | |
LVTX LAVA Therapeutics | Reiterates: Neutral | 2 2 | 1.24 | 20.97% | 10 | Mar 31, 2025 | |
PRME Prime Medicine | Reiterates: Buy | 10 10 | 1.74 | 474.71% | 7 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 7 7 | 0.78 | 733.33% | 3 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 16 20 | 3.66 | 446.45% | 9 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 7 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 20 9 | n/a | n/a | 17 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 39 | n/a | n/a | 4 | May 28, 2024 |